# Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors

> **NCT01999738** · PHASE1 · COMPLETED · sponsor: **Endocyte** · enrollment: 93 (actual)

## Conditions studied

- Solid Tumors
- Non Small Cell Lung Carcinoma

## Interventions

- **DRUG:** EC1456 and EC20

## Key facts

- **NCT ID:** NCT01999738
- **Lead sponsor:** Endocyte
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-04-26
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2019-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999738, "Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01999738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*